When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Abnormal uterine bleeding

Evidence last reviewed: 19 Oct 2026
Topic last updated: 21 Jul 2026

Summary

Definition

History and exam

Key diagnostic factors

  • uterine bleeding
Full details

Other diagnostic factors

  • use of medications
  • menstrual irregularity
  • anemia
  • premenstrual molimina
  • hirsutism, acne, acanthosis nigricans
  • existing medical illness
Full details

Risk factors

  • women at the extremes of reproductive age (just after puberty and before menopause)
  • polycystic ovary syndrome
  • endocrine disorders
  • other anovulatory disorders
  • obesity
Full details

Diagnostic tests

1st tests to order

  • pregnancy test
  • CBC
Full details

Tests to consider

  • coagulation profile
  • serum TSH level
  • ultrasound scan
  • hysteroscopy
  • endometrial biopsy
Full details

Treatment algorithm

INITIAL

emergency management of excessive uterine bleeding

ACUTE

anovulatory AUB: progestogens and estrogens not contraindicated

anovulatory AUB: progestogens and estrogens contraindicated

ONGOING

significant uterine bleeding resistant to medical treatment; desiring future fertility

significant uterine bleeding resistant to medical treatment; not desiring future fertility

Contributors

Authors

Janesh Gupta, MSc, MD, FRCOG

Professor of Obstetrics and Gynaecology

Centre for Women's and Newborn Health

Institute of Metabolism and Systems Research

University of Birmingham

Birmingham Women’s and Children’s Hospital

Birmingham

UK

Disclosures

JG is a clinical advisor for Femcare UK. 

Akanksha Sood, MBBS, MS (OBGY), DNB, MRCOG, FACOG

Senior Clinical Fellow

Department of Reproductive Medicine

St. Mary’s Hospital

Manchester

UK

Disclosures

AS declares that she has no competing interests.

Rohan Chodankar, MBBS, MD, MRCOG

ST6 Obstetrics and Gynaecology

Royal Infirmary of Edinburgh

Scotland

UK

Disclosures

RC is supported as a Clinical Research Fellow by Bayer AG; RC is an author of references cited in this topic.

Acknowledgements

Professor Gupta, Dr Sood, and Dr Chodankar would like to gratefully acknowledge Dr Mohamed Mitwally and Dr Intisar Elnahhas, the previous contributors to this topic.

Disclosures

MM owns a patent on the use of aromatase inhibitors for endometrial thinning before hysteroscopic surgery. The patent is licensed to Meditrina Company. IE declares that she has no competing interests.

Peer reviewers

Janet Albers, MD

Associate Professor

Department of Family and Community Medicine

Southern Illinois University School of Medicine

Springfield

IL

Declarações

JA is an author of a reference cited in this topic.

Sarina Schrager, MD, MS

Associate Professor (CHS)

Department of Family Medicine

University of Wisconsin

WI

Declarações

SS declares that she has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011 Apr;113(1):3-13. Resumo

National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. Jul 2026 [internet publication].Texto completo

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Jul 2012 [internet publication].Texto completo

American College of Obstetricians and Gynecologists. ACOG committee opinion no. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Apr 2013 [internet publication].Texto completo

American College of Obstetricians and Gynecologists. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Jul 2013 [internet publication].Texto completo

National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. May 2021 [internet publication].Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Pregnancy-related bleeding
    • Menstrual-related migraine
    • Genital lesions
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Heavy menstrual bleeding: assessment and management
    • General approaches to medical management of menstrual suppression
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Heavy periods

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal